Altimmune
ALT
ALT
103 hedge funds and large institutions have $207M invested in Altimmune in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+1
Holders Change %
+0.98%
% of All Funds
1.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
35
Reduced
31
Closed
19
Calls
$4.98M
Puts
$534K
Net Calls
+$4.45M
Net Calls Change
+$1.17M
Top Buyers
| 1 |
1
Nuveen Asset Management
Chicago,
Illinois
|
$22.2M |
| 2 |
TCM
2
Tang Capital Management
San Diego,
California
|
$15.7M |
| 3 |
VA
3
VR Adviser
New York
|
$4.63M |
| 4 |
4
Millennium Management
New York
|
$4.25M |
| 5 |
ACM
5
Altium Capital Management
New York
|
$1.96M |
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$4.21M |
| 2 |
2
Rafferty Asset Management
New York
|
$0 |
| 3 |
3
Citigroup
New York
|
$4.81M |
| 4 |
4
D.E. Shaw & Co
New York
|
$5.89M |
| 5 |
5
Bank of America
Charlotte,
North Carolina
|
$140K |
